• SPX
  • $5,953.49
  • 0.61 %
  • $36.38
  • DJI
  • $43,947.05
  • 1.24 %
  • $538.57
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $19,000.06
  • 0.18 %
  • $33.92
Incannex Healthcare Limited (IXHL) Stock Price, News & Analysis

Incannex Healthcare Limited (IXHL) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.05

-$0.04

(-1.91%)

Day's range
$2.03
Day's range
$2.11
50-day range
$1.52
Day's range
$3.12
  • Country: AU
  • ISIN: US45333F1093
52 wk range
$0.95
Day's range
$12.68
  • CEO: Mr. Joel Bradley Latham
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -10.77
  • Piotroski Score 0.00
  • Grade N/A
  • Symbol (IXHL)
  • Company Incannex Healthcare Limited
  • Price $2.05
  • Changes Percentage (-1.91%)
  • Change -$0.04
  • Day Low $2.03
  • Day High $2.11
  • Year High $12.68

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/03/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.27
  • Trailing P/E Ratio -2.56
  • Forward P/E Ratio -2.56
  • P/E Growth -2.56
  • Net Income $-18,459,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Incannex Healthcare Limited Frequently Asked Questions

  • What were the earnings of IXHL in the last quarter?

    In the last quarter Incannex Healthcare Limited earnings were on Monday, September, 30th. The Incannex Healthcare Limited maker reported -$0.39 EPS for the quarter, beating analysts' consensus estimates of -$0.72 by $0.33.

  • What is the Incannex Healthcare Limited stock price today?

    Today's price of Incannex Healthcare Limited is $2.05 — it has decreased by -1.91% in the past 24 hours. Watch Incannex Healthcare Limited stock price performance more closely on the chart.

  • Does Incannex Healthcare Limited release reports?

    Yes, you can track Incannex Healthcare Limited's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Incannex Healthcare Limited stock forecast?

    Watch the Incannex Healthcare Limited chart and read a more detailed Incannex Healthcare Limited stock forecast to see what analysts suggest you do with its shares.

  • What is Incannex Healthcare Limited stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Incannex Healthcare Limited stock ticker.

  • How to buy Incannex Healthcare Limited stocks?

    Like other stocks, IXHL shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Incannex Healthcare Limited's EBITDA?

    Incannex Healthcare Limited measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Incannex Healthcare Limited’s financial statements.

  • What is the Incannex Healthcare Limited's net income ratio for the financial year 2024?

    The net income ratio for the financial year 2024 is -1538.25, which equates to approximately -153,825.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Incannex Healthcare Limited stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Incannex Healthcare Limited's financials relevant news, and technical analysis. Incannex Healthcare Limited's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Incannex Healthcare Limited stock currently indicates a “sell” signal. For more insights, review Incannex Healthcare Limited’s technical analysis.

  • A revenue figure for Incannex Healthcare Limited for its last quarter?

    Incannex Healthcare Limited published it's last quarterly revenues at $12,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.